Correlation Between Enlivex Therapeutics and Purple Biotech
Can any of the company-specific risk be diversified away by investing in both Enlivex Therapeutics and Purple Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enlivex Therapeutics and Purple Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enlivex Therapeutics and Purple Biotech, you can compare the effects of market volatilities on Enlivex Therapeutics and Purple Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enlivex Therapeutics with a short position of Purple Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enlivex Therapeutics and Purple Biotech.
Diversification Opportunities for Enlivex Therapeutics and Purple Biotech
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between Enlivex and Purple is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Enlivex Therapeutics and Purple Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Purple Biotech and Enlivex Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enlivex Therapeutics are associated (or correlated) with Purple Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Purple Biotech has no effect on the direction of Enlivex Therapeutics i.e., Enlivex Therapeutics and Purple Biotech go up and down completely randomly.
Pair Corralation between Enlivex Therapeutics and Purple Biotech
Given the investment horizon of 90 days Enlivex Therapeutics is expected to under-perform the Purple Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Enlivex Therapeutics is 1.4 times less risky than Purple Biotech. The stock trades about -0.24 of its potential returns per unit of risk. The Purple Biotech is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 307.00 in Purple Biotech on August 28, 2024 and sell it today you would lose (33.00) from holding Purple Biotech or give up 10.75% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enlivex Therapeutics vs. Purple Biotech
Performance |
| Timeline |
| Enlivex Therapeutics |
| Purple Biotech |
Enlivex Therapeutics and Purple Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enlivex Therapeutics and Purple Biotech
The main advantage of trading using opposite Enlivex Therapeutics and Purple Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enlivex Therapeutics position performs unexpectedly, Purple Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Purple Biotech will offset losses from the drop in Purple Biotech's long position.| Enlivex Therapeutics vs. Pluri Inc | Enlivex Therapeutics vs. BioLineRx | Enlivex Therapeutics vs. Purple Biotech | Enlivex Therapeutics vs. Histogen |
| Purple Biotech vs. Pluri Inc | Purple Biotech vs. BioLineRx | Purple Biotech vs. Enlivex Therapeutics | Purple Biotech vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |